http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554395-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106554395-B |
| titleOfInvention | A kind of long acting erythropoietin simulating peptide and its preparation method and application |
| abstract | The present invention relates to a kind of Erythropoietin mimetic peptide derivative and its officinal salt with long-acting promoting erythrocyte systematic function.The present invention also provides the preparation method of above-mentioned Erythropoietin mimetic peptide derivative and its be used to prepare treatment by lack red blood cell lack erythropoietin(EPO) or red cell population lack or defect characterized by disease drug in purposes.Wherein, Erythropoietin mimetic peptide derivative provided by the invention polypeptide as shown in SEQ ID NO:1GGLYACHMGPITNalVCQPLRSarKVPGPGVPGPGVPGPGVPGPG; wherein, two cysteines of the polypeptide form disulfide bond, N-terminal acetylation. |
| priorityDate | 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 239.